Several studies reported an induction and binding of FGF2 to the plaques and neurofibrillary tangles in brains affected by Alzheimer’s disease [240,241,242], and in cerebrospinal fluid (CSF) obtained from Alzheimer’s disease patients [243]. This evidence concerns the gene FGF2 and early-onset autosomal dominant Alzheimer disease.